|
12
|
52
|
2wygB |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with monoaryl p4 motifs |
|
9
|
59
|
2wpiE |
Factor ixa superactive double mutant |
|
10
|
59
|
2wpmE |
Factor ixa superactive mutant, egr-cmk inhibited |
|
11
|
52
|
2wyjB |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with monoaryl p4 motifs |
|
8
|
59
|
2wpjE |
Factor ixa superactive triple mutant, nacl-soaked |
|
88
|
452
|
2wg4B |
Crystal structure of the complex between human hedgehog-interacting protein hip and sonic hedgehog without calcium |
|
11
|
59
|
2wpkE |
Factor ixa superactive triple mutant, ethylene glycol-soaked |
|
13
|
59
|
2wphE |
Factor ixa superactive triple mutant |
|
10
|
59
|
2wplE |
Factor ixa superactive triple mutant, edta-soaked |
|
83
|
425
|
2wg3C |
Crystal structure of the complex between human hedgehog-interacting protein hip and desert hedgehog without calcium |
|
84
|
452
|
2wfxB |
Crystal structure of the complex between human hedgehog-interacting protein hip and sonic hedgehog in the presence of calcium |
|
30
|
147
|
2w86A |
Crystal structure of fibrillin-1 domains cbegf9hyb2cbegf10, calcium saturated form |
|
100
|
458
|
2wftA |
Crystal structure of the human hip ectodomain |
|
7
|
48
|
2w2pE |
Pcsk9-deltac d374a mutant bound to wt egf-a of ldlr |
|
7
|
49
|
2w2mE |
Wt pcsk9-deltac bound to wt egf-a of ldlr |
|
9
|
51
|
2vwoL |
Aminopyrrolidine factor xa inhibitor |
|
50
|
205
|
2vrsA |
Structure of avian reovirus sigmac117-326, c2 crystal form |
|
8
|
47
|
2w2oE |
Pcsk9-deltac d374y mutant bound to wt egf-a of ldlr |
|
11
|
51
|
2w3kB |
Crystal structure of fxa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 |
|
10
|
51
|
2vwnL |
Aminopyrrolidine factor xa inhibitor |
|
8
|
47
|
2w2qE |
Pcsk9-deltac d374h mutant bound to wt egf-a of ldlr |
|
12
|
53
|
2vvcK |
Aminopyrrolidine factor xa inhibitor |
|
11
|
51
|
2w26B |
Factor xa in complex with bay59-7939 |
|
10
|
53
|
2vwmK |
Aminopyrrolidine factor xa inhibitor |
|
9
|
50
|
2vwlL |
Aminopyrrolidine factor xa inhibitor |
|
12
|
54
|
2vvuL |
Aminopyrrolidine factor xa inhibitor |
|
8
|
49
|
2w2nE |
Wt pcsk9-deltac bound to egf-a h306y mutant of ldlr |
|
12
|
54
|
2vvvL |
Aminopyrrolidine-related triazole factor xa inhibitor |
|
12
|
51
|
2w3iB |
Crystal structure of fxa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 |
|
12
|
52
|
2vh0B |
Structure and property based design of factor xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs |
|
12
|
52
|
2uwlB |
Selective and dual action orally active inhibitors of thrombin and factor xa |
|
21
|
120
|
2vj3A |
Human notch-1 egfs 11-13 |
|
12
|
52
|
2uwpB |
Factor xa inhibitor complex |
|
12
|
54
|
2vh6B |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with biaryl p4 motifs |
|
12
|
52
|
2uwoB |
Selective and dual action orally active inhibitors of thrombin and factor xa |
|
12
|
51
|
2ra0L |
X-ray structure of fxa in complex with 7-fluoroindazole |
|
2
|
50
|
2rnlA |
Solution structure of the egf-like domain from human amphiregulin |
|
160
|
622
|
2rhpA |
The thrombospondin-1 polymorphism asn700ser associated with cornoary artery disease causes local and long-ranging changes in protein structure |
|
13
|
50
|
2tgfA |
The solution structure of human transforming growth factor alpha |
|
12
|
51
|
2q1jB |
The discovery of glycine and related amino acid-based factor xa inhibitors |
|
9
|
51
|
2p3fL |
Crystal structure of the factor xa/nap5 complex |
|
11
|
50
|
2pr3B |
Factor xa inhibitor |
|
177
|
553
|
2oyuP |
Indomethacin-(s)-alpha-ethyl-ethanolamide bound to cyclooxygenase-1 |
|
69
|
280
|
2p26A |
Structure of the phe2 and phe3 fragments of the integrin beta2 subunit |
|
13
|
52
|
2p95L |
Factor xa in complex with the inhibitor 5-chloro-n-((1r,2s)-2-(4-(2-oxopyridin-1(2h)-yl)benzamido) cyclopentyl)thiophene-2-carboxamide |
|
10
|
51
|
2phbB |
An orally efficacious factor xa inhibitor |
|
17
|
94
|
2puqL |
Crystal structure of active site inhibited coagulation factor viia in complex with soluble tissue factor |
|
13
|
52
|
2p94L |
Factor xa in complex with the inhibitor 3-chloro-n-((1r,2s)-2-(4-(2-oxopyridin-1(2h)-yl)benzamido)cyclohexyl)-1h-indole-6-carboxamide |
|
12
|
52
|
2p3tA |
Crystal structure of human factor xa complexed with 3-chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide |
|
13
|
52
|
2p93L |
Factor xa in complex with the inhibitor 5-chloro-n-(2-(4-(2-oxopyridin-1(2h)-yl)benzamido)ethyl)thiophene-2-carboxamide |
